Care

Michael Abrams of Numerof and Associates says that oversight for AI used in mental health care should mirror that of pharmaceuticals, with clear standards, safety testing and ongoing monitoring.

The San Francisco-based lab will house Eli Lilly experts in biology, science and medicine alongside NVIDIA AI model builders and engineers.

The CEO of Transcarent sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss AI's place in healthcare and its use in expanding access.

Seoul National University Hospital researchers have developed an AI model that predicts the response to an anticonvulsant drug.

Dr. Baligh Yehia, Jefferson Health's president, says the health system will use AI to streamline scheduling, tackle revenue cycle challenges, close care gaps and give clinicians back 10 million patient hours over the next three years.

Private rheumatologist Dr Anandita Santosa in Singapore notes how current AI in healthcare priorities practically leave autoimmune and rheumatic diseases behind and shares what can be done to build a more comprehensive AI-driven preventive care ecosystem.

Clinician innovators across the region see the next phase of healthcare AI focusing on trust and responsible adoption after a year of rapid experimentation.

Predictions from Australia to Southeast Asia highlight where AI, telehealth, and platform consolidation are headed next.

Eitan Okun, head of the Paul Feder Laboratory for Alzheimer's Disease Research at Bar-Ilan University, studies aging individuals and he is currently evaluating the link between maternal cognitive decline and pregnancy with a Down syndrome fetus.

The company, which made the announcement at the JPM Healthcare Conference in San Francisco, will use the funds to expand its AI-powered Halo Intelligence platform.